Twitter Facebook LinkedIn YouTube

The Canadian Bioceutical Corporation (CSE: BCC) New Listing

Video Platform Video Management Video Solutions Video Player

The company recently announced that, together with its wholly owned subsidiary CGX Life Sciences, a Nevada incorporated entity, it has completed the acquisition of a group of companies active in the Arizona market for medical cannabis.

Additional Information:

Company: The Canadian Bioceutical Corporation
Website: http://www.canadianbioceutical.com
Stock Symbol: CSE: BCC
Date Published: Jan 30, 2017
Transcript: Available

Video Transcript:

I’m Bethany Rae Cornish for Investmentpitch Media

The Canadian Bioceutical Corporation is the latest new listing on the Canadian Securities Exchange, and trades under the symbol “BCC”, having transferred its listing from the TSX Venture Exchange.

The company recently announced that, together with its wholly owned subsidiary CGX Life Sciences, a Nevada incorporated entity, it has completed the acquisition of a group of companies active in the Arizona market for medical cannabis.

Located in Ontario, Canadian Bioceutical through its wholly owned subsidiaries in the U.S. provides a full range of services including management, staffing, financial and administrative services to two medicinal cannabis enterprises in Arizona.

Under the terms of the management agreement, CGX will support two existing brands in Arizona.

Under the Health for Life ("H4L") brand, two licensed dispensaries operate in the Mesa area, selling dried flower and derivative cannabis product to authorized patients.

Additionally, the company supports the Melting Point Extracts ("MPX") brand, which is focused
predominantly on the sale of derivative cannabis products, such as oils, through its dispensaries and
through its wholesale business to other Arizona dispensaries.

As part of the acquisition, the company acquired an option to purchases a controlling interest in GreenMart of Nevada, for US$9 million.

GreenMart is a cultivation and wholesale business located in Las Vegas, with a production capacity of approximately 1.6 million grams of dried flower and 85,000 grams of concentrate per year.

Concurrent with this acquisition, the company completed a private placement for gross proceeds of US$27 million, facilitated by London based Chrystal Capital Partners (www.chrystalcapital.com)

Scott Boyes, President and CEO, stated: “This transaction, we believe, makes us the most profitable cannabis company listed in Canada. More than that, it creates a platform for growth in a number of very attractive U.S. markets, which are forecast to reach US$22 billion by 2020. To create further shareholder value, we are pursuing a two-tier strategy. Firstly, we are expanding the production capacity of our Arizona operations, and will leverage the performance and strength of our brands to drive continued organic growth. We will support this growth through expanded production capacity, as well as the use of
innovative technology. Secondly, we will pursue attractively priced acquisition opportunities throughout
the U.S. Many operations in the U.S., though profitable, are small and undercapitalized and require a
financially strong partner to pursue further growth. The strength of our balance sheet, with growing cash
flow positive operations, and our proven access to capital, create the financial fire power required to
implement this strategy.”

The company also leases a property in Owen Sound, Ontario, for which an application to Health Canada has been made for a cannabis production and sales license.

The shares are trading at $1.00, and with 224 million shares outstanding, the company is capitalized at $224 million.

For more information about the company, please visit the company’s website www.canadianbioceutical.com, contact Scott Boyes, President and CEO, at 416-840-3725 or by email info@canadianbioceutical.com.

Investor relations is handled by Marc Lakmaaker of NATIONAL Equicom, who can be reached at 416-848-1397 or by email at mlakmaaker@national.ca. I’m Bethany Rae Cornish for Investmentpitch Media